Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2779

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-2779). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A dot plot chart showing fold changes with 90% confidence intervals for venlafaxine and its active metabolite ODV pharmacokinetic parameters (Cmax and AUC). The chart compares different special populations, including hepatic and renal impairments, CYP2D6 metabolizer status, age above 60 years, and gender, relative to a reference value.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A scatter plot showing fold change and 90% confidence intervals for various interacting drugs on venlafaxine pharmacokinetics. The chart compares the change in Cmax and AUC for venlafaxine and its active metabolite ODV relative to reference values with drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A scatter plot chart depicting the fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax and AUC) for various analytes when interacted with drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis shows fold changes relative to a reference value ranging from 0 to 3, with each drug-analyte pair marked to indicate the extent of change.*
FDA Label Image

Label (Lbl713352779)

Label (Lbl713352779)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 37.5 mg strength. The bottle contains 30 capsules. The product is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Granules India Limited. The label features the NDC 71335-2779-1 and storage instructions.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of venlafaxine hydrochloride showing its molecular components, including a substituted cyclohexane ring, a dimethylaminoethyl side chain, and associated hydrochloride (HCl) salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.